MabThera Targeted Therapies

MabThera for Second-Line or Relapsed Chronic Lymphocytic Leukaemia

MabThera (also known as rituxmab) is used to treat people with Chronic Lymphocytic Leukaemia. It is usually given in conjunction with chemotherapy.

MabThera as a Maintenance Treatment for Follicular Lymphoma

Mabthera is a targeted therapy which has been used in the treatment of people with Non-Hodgkin’s Lymphoma, in particular those with follicular lymphoma.